Peripheral Vascular Disease (PVD) Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Notes from ACC — Day 3 (Final Day)
Sorry this took most of the week to get out. (There was a good reason.) Better late than never I suppose. On Day 3 of the 2013 American College of Cardiology meeting, I woke up well rested and inspired to squeeze in as much learning as possible. The first order of business was putting the final touches on the athletes and atrial fibrillation piece. (The big question was whether to keep the line about love?) Here is the post: Does exercise cause myocardial fibrosis: Please don’t say too much exercise can cause heart disease? My THO assignment for the final day was to find something useful to say about catheter ablatio...
Source: Dr John M - March 16, 2013 Category: Cardiology Authors: Dr John Source Type: blogs

Mercator Micro-Infusion Catheters for Targeted Drug Injection Inside Body CE Marked in EU
Mercator MedSystems (San Leandro, CA) received European regulator approval to bring to market its Bullfrog and Cricket micro-infusion catheters. Already approved for use in the U.S., the catheters were designed to deliver medications through blood vessel walls directly to tissue deep inside the body. This technique keeps the injected agent at high concentration near the target and helps it from spreading into the rest of the body.The company is envisioning the catheters to be used for “plaque stabilization in diseased vessels, anti-tumor drugs, growth factors to stimulate cell division, and stem cell transplantatio...
Source: Medgadget - March 1, 2013 Category: Technology Consultants Authors: Gene Ostrovsky Tags: Medicine Vascular Surgery Source Type: blogs

ACE Inhibitor Improves Walking In People with Peripheral Artery Disease
Giving an ACE inhibitor to people with peripheral artery disease (PAD) and intermittent claudication reduces pain and increases walking time, according to a new study published in JAMA. Currently the pharmacologic options for this patient population are few and have limited efficacy. Researchers at three Australian hospitals randomized 212 patients with PAD to receive the ACE inhibitor ramipril or placebo for 24 weeks. Compared to the patients on placebo, patients on the ACE inhibitor had a mean 75 second increase in their pain-free walking time (156 seconds in the placebo group versus 229 seconds in the More… (Source: CardioBrief)
Source: CardioBrief - February 5, 2013 Category: Cardiology Authors: Larry Husten Tags: Prevention, Epidemiology & Outcomes ace inhibitor PAD peripheral artery disease Peripheral vascular disease ramipril Source Type: blogs

Walking Improves With ACE Inhibitor In People with Peripheral Artery Disease
Giving an ACE inhibitor to people with peripheral artery disease (PAD) and intermittent claudication reduces pain and increases walking time, according to a new study published in JAMA. Currently the pharmacologic options for this patient population are few and have limited efficacy. Researchers at three Australian hospitals randomized 212 patients with PAD to receive the ACE inhibitor ramipril or placebo for 24 weeks. Compared to the patients on placebo, patients on the ACE inhibitor had a mean 75 second increase in their pain-free walking time (156 seconds in the placebo group versus 229 seconds in the More… (Source: CardioBrief)
Source: CardioBrief - February 5, 2013 Category: Cardiology Authors: Larry Husten Tags: Prevention, Epidemiology & Outcomes ace inhibitor PAD peripheral artery disease Peripheral vascular disease ramipril Source Type: blogs